Fig. 1From: Comparing angiotensin receptor–neprilysin inhibitors with sodium–glucose cotransporter 2 inhibitors for heart failure with diabetes mellitusStudy flowchart. ARNI angiotensin receptor–neprilysin inhibitor, DM diabetes mellitus, ESRD end-stage renal disease, HbA1c glycohemoglobin, HFrEF heart failure with reduced ejection fraction, SGLT2i sodium–glucose cotransporter 2 inhibitorsBack to article page